Fluoxymestérone saupoudre des stéroïdes de renforcement musculaire pour les culturistes

Fluoxymestérone saupoudre des stéroïdes de renforcement musculaire pour les culturistes

Halotestin

Détails du produit

n ° CAS: 76-43-7

Essai: 99%

Lieu d'origine: Chine

Quality standard: Norme d'entreprise

Mots clés : la musculation , hormone stéroïde , raw material powder

Masse moléculaire: C20H29FO3

Formule moléculaire: C20H29FO3

Apparence: Poudre cristalloïde blanche.

Applications

Be used to promote male genital growth and keep their normal function, similar to the role and application of methyl testosterone, is characterized by slower metabolism in the body, the effect lasted longer.

Halotestin is an anabolic steroide with strong androgenic properties that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. It is approximately 5 times as potent as methyltestosterone. The antitumor activity of halotestin appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.

Caractéristiques

Estrogenic:

Although a testosterone derived anabolic steroid, Halotestin does not aromatize and will not produce estrogenic related side effects. Water retention and gynecomastia are impossible with this steroid. The concurrent use of an anti-estrogen with Halotestin will present no benefit. An anti-estrogen may be needed depending on the other compounds in the cycle, but it is not necessary due to Halotestin use.

Androgenic:

Halo is an extraordinarily androgenic steroid, and as a result, the side effects of Halotestin can surround a strong androgenic nature. This can include acne, accelerated hair loss in those predisposed to male pattern baldness and body hair growth. While such effects are strongly dependent on individual response and genetic predispositions, the androgenic power of Halo greatly increases the odds. This power is so great, some studies have suggested that Fluoxymesterone may actually promote phallic enlargement.

Halotestin is greatly affected by the 5-alpha reductase enzyme, the same enzyme responsible for the reduction of testosterone to dihydrotestosterone. For this reason, the use of a 5-alpha reductase inhibitor such as Finasteride may reduce the related androgenic side effects of Halotestin. Such use will not completely subdue this steroid’s androgenic activity, but it could potentially reduce it. Cependant, those who are strongly susceptible to androgenic side effects will probably need to forgo this steroid’s use.